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HOSPITAL VARIATION IN ADMISSION TO INTENSIVE CARE UNITS FOR PATIENTS WITH
MYOCARDIAL INFARCTION. RuiJun Chen, Kelly M. Strait, Kumar Dharmarajan, Shu-Xia Li,
Isuru Ranasinghe, John Martin, Reza Fazel, Frederick A. Masoudi, Colin R. Cooke, Brahmajee K.
Nallamothu, and Harlan M. Krumholz. Section of Cardiovascular Medicine, Department of Internal
Medicine, Yale University, School of Medicine, New Haven, CT.

The treatment of patients with myocardial infarction was transformed by the introduction of
intensive care units (ICUs), but we know little about how contemporary hospitals employ this
resource-intensive setting and whether higher use is associated with better outcomes. We sought
to determine the variation in the rates of ICU admission across hospitals for patients with
myocardial infarction and whether these rates were associated with mortality or usage of critical
care therapies. We hypothesized that large variations exist in rates of ICU use for these patients
across hospitals, but that these differences would not be associated with in-hospital mortality. We
identified 114,980 adult hospitalizations for acute myocardial infarction from 311 hospitals in the
2009-10 Premier database using codes from the International Classification of Diseases, Ninth
Revision, Clinical Modification. Hospitals were stratified into quartiles by rates of ICU admission
for patients with myocardial infarction. Across quartiles, we examined in-hospital riskstandardized mortality rates and usage rates of critical care therapies for these patients. Rates of
ICU admission for patients with myocardial infarction varied markedly among hospitals (median
48%, IQR 35%-61%, range 0%-98%) and there was no association with in-hospital riskstandardized mortality rates (6% all quartiles; p=0.7). However, hospitals admitting more patients
to the ICU were more likely to use critical care therapies overall (mechanical ventilation [from
Quartile 1 with lowest rate of ICU use to Quartile 4 with highest rate: 13% to 16%],
vasopressors/inotropes [17% to 21%], intra-aortic balloon pumps [4% to 7%], and pulmonary
artery catheters [4% to 5%]; p for trend<0.05 in all comparisons). Rates of ICU admission for
myocardial infarction vary substantially across hospitals and were not associated with differences
in mortality, but were associated with greater use of critical care therapies.
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Introduction
Contemporary intensive care units transformed the care of patients with
myocardial infarction at a time when few effective therapies were available. The
concept of the intensive observation of critically ill patients with readily available,
specialized interventions is an idea deeply rooted in history, which has been
referenced in writings throughout numerous civilizations dating back to ancient
Egypt.1 The modern implementation of intensive care in the United States began
in the 1920s, with a 3 bed unit for postoperative neurosurgical patients at the
Johns Hopkins Hospital. However, intensive care units gained little traction until
this concept of a specialized unit for the critically ill and the development of novel
life-sustaining technologies coalesced in the late 1950s.2 This technological
revolution included new machines capable of positive pressure ventilation,
spurred by the polio epidemic, dialysis, external defibrillators, synchronized
cardioversion, and even the less technologically advanced yet vital conception of
external cardiopulmonary resuscitation techniques.3
Once hospitals began widely adopting intensive care units in the early
1960s and rapidly specialized into the development of coronary care units,
patients with myocardial infarctions finally had readily available access to
continuous electrocardiographic monitoring, invasive or resuscitative
technologies, and higher nursing to patient ratios.4,5 Their initial adoption
improved outcomes for these patients in an era when short-term mortality rates
were high and complications such as post-infarction ventricular arrhythmias were
common. Several studies showed that patients with acute myocardial infarctions
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who were triaged to an intensive care unit had approximately 20% lower mortality,
notably decreasing from 26% to 7% in the Killip’s landmark study of 250 patients
over 2 years.6,7 As a result, approximately 60% of all hospitals in the United
States had a coronary care unit within the next 10 years, and routine admission
to an intensive care unit was quickly and widely accepted as the standard of care
for most patients with myocardial infarction.8 This standard has continued to be
strongly endorsed by clinical practice guidelines into the modern era, as recent
American College of Cardiology and American Heart Association guidelines prior
to 2013 strongly recommended admission to a critical care unit for all patients
with an ST-elevation myocardial infarction as well as those with a non STelevation myocardial infarction and “active, ongoing ischemia/injury or
hemodynamic or electrical instability.9,10 These represented Class I
recommendations, the highest recommendation level possible, but held only a
level of evidence C, indicating that they were based on expert opinion rather than
modern supporting evidence.
Today, given the marked evolution in the clinical care and evidence base
for myocardial infarction, the value of intensive care units for many of these
patients in contemporary practice warrants closer scrutiny. Non-critical care
wards now possess the capability to provide telemetry monitoring and advanced
therapies previously limited to intensive care units, such as the administration of
intravenous anti-arrhythmic agents.2,11 Simultaneously, the prognosis of patients
with myocardial infarction has substantially improved as ST-segment elevation
myocardial infarctions, complications including shock and heart failure, and short-
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term mortality have all declined, raising questions about which contemporary
patients truly benefit from being in an intensive care unit.12-17 Finally, intensive
care units are not only increasingly expensive, as they account for only 5-10% of
total beds but 20-34% of nationwide hospital costs,18,19 but also facilitate the
implementation of resource-intensive strategies that, while essential for some
patients, may be discretionary in others.20-22 In part because of uncertainty about
the marginal benefit of intensive care units for many patients, the most recent
version of the American College of Cardiology and American Heart Association
guidelines on myocardial infarction no longer contain specific recommendations
on intensive care unit use.23,24 Meanwhile, little is known about how hospitals use
this resource and whether higher rates of intensive care unit use are associated
with better outcomes.

Purpose, Hypothesis, and Aims
Accordingly, we sought to describe hospital variation in the use of
intensive care units and associated outcomes for patients with myocardial
infarction in a large contemporary sample of hospitals in the United States. We
hypothesized that large variations would exist in the rates of intensive care unit
use for these patients across hospitals, but that these differences in use would
not be associated with any differences in in-hospital mortality. Further, we
explored the relationship between hospital rates of intensive care unit use and
the utilization of resource-intensive treatment strategies in the overall cohort of
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patients with myocardial infarction and the subset of these patients admitted to
an intensive care unit.

Methods
Data Source
We conducted a retrospective cohort study using a voluntary, feesupported database maintained by Premier, Inc. for measuring quality and
healthcare utilization. Through 2010, the Premier database contained data on
more than 325 million cumulative hospital discharges, with over 90 million
discharges from 2009-2010 alone, representing approximately 1 out of every 5
hospital discharges nationwide. In addition to information available in standard
hospital discharge files, this database contains a date-stamped log of all billed
items at the patient level including diagnostic tests, medications, and therapeutic
services. Patient data were de-identified in accordance with the Health Insurance
Portability and Accountability Act and a random hospital identifier assigned by
Premier was used to identify the hospitals. The Yale University Human
Investigation Committee reviewed the protocol for this study and determined that
it is not considered to be Human Subjects Research as defined by the Office of
Human Research Protections.

Study Population
We included all hospitalizations from January 1, 2009 to December 31,
2010 for patients aged 18 years or older with a principal discharge diagnosis of

5

acute myocardial infarction as defined by the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 410.xx. We
excluded ICD-9-CM codes representing subsequent episodes of care (410.x2)
and all hospitalizations involving transfers, as we could not link hospitalizations
across different institutions and would be unable to capture their full hospital
course. Furthermore, we excluded hospitals with fewer than 25 admissions for
myocardial infarction over the study period to decrease the likelihood of
artifactual findings from small sample sizes. We also excluded hospitals with no
intensive care unit hospitalizations for myocardial infarction to ensure that
hospitals would not lack an intensive care unit as an option for hospitalized
patients.

Study Variables
Intensive Care Unit Admission Rates. For each hospital, we identified
the proportion of hospitalizations for acute myocardial infarction that were directly
admitted to an intensive care unit. We defined direct admission to an intensive
care unit as having a room and board charge for a medical, coronary, surgical, or
general intensive care unit bed during the first hospital day. We did not include
step-down units due to the lack of reliability in coding for these beds as well as
the lack of availability of step-down units in a significant proportion of hospitals.
We then assessed intensive care unit admission patterns among four distinct
subgroups of hospitalizations for myocardial infarction: 1) patients with STsegment elevation myocardial infarctions, 2) patients with non-ST-segment
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elevation myocardial infarctions, 3) patients receiving reperfusion therapy, and 4)
patients not receiving reperfusion therapy. We chose to study variation further
across these subgroups due to the possibility that these patients may differ in
their acuity of illness and/or their monitoring needs. ST-segment elevation
myocardial infarctions were identified using ICD-9-CM codes 410.0 through
410.8 (excluding 410.7).12 Non-ST-segment elevation myocardial infarctions
were identified using ICD-9-CM code 410.7.25 Reperfusion therapy was defined
as either thrombolysis or percutaneous coronary intervention provided at any
time during hospitalization.

Mortality. For each hospital, we calculated in-hospital all-cause riskstandardized mortality rates for 1) all patients with myocardial infarction and 2)
intensive care unit patients with myocardial infarction—defined as the subset of
all patients with myocardial infarction who were directly admitted to an intensive
care unit.

Use of Critical Care Therapy. For each hospital, we calculated the use of
critical care therapies among 1) all patients with myocardial infarction and 2)
intensive care unit patients with myocardial infarction. For these outcomes, we
hypothesized that hospitals with higher rates of intensive care unit use would be
more likely to use critical care therapies in their overall cohort of patients with
myocardial infarction due to greater discretionary use and a gatekeeper effect
granting more patients access to such therapies. In contrast, we postulated such
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therapies would be less likely to be used in their intensive care unit patient
subgroups due to a higher proportion of low-risk patients in the intensive care
unit. Critical care therapies were defined as therapies for myocardial infarction
that are typically available only in an intensive care unit, including the use of
mechanical ventilation, intravenous vasopressors or inotropes, intra-aortic
balloon pumps, and/or pulmonary artery catheters.

Length of Stay. For each hospital, we calculated the length of stay for 1)
all patients with myocardial infarction and 2) intensive care unit patients with
myocardial infarction.

Statistical Analysis
Results for categorical variables are reported as percentages. Results for
continuous variables are reported with medians and interquartile ranges.
Hospitals were categorized into quartiles based on the proportion of all
hospitalizations for myocardial infarction admitted to an intensive care unit, with
the top quartile (quartile 4) having the highest rates of admission and the bottom
quartile (quartile 1) having the lowest rates. Hospital characteristics, mortality,
critical care therapies, and length of stay were assessed across quartiles.
For 1) all patients with myocardial infarction and 2) intensive care unit
patients with myocardial infarction, we calculated in-hospital risk-standardized
mortality rates for each hospital using hierarchical logistic regression, employing
methods that are used in the outcomes measures publicly reported by the

8

Centers for Medicare & Medicaid Services.26,27 We adjusted for patient
characteristics including age and comorbidities (Table 1) classified using the
software provided by the Healthcare Costs and Utilization Project of the Agency
for Healthcare Research and Quality.28 Variables were selected using a stepwise
algorithm.

Table 1. Selected Comorbidities.
Used in ICU

Used in Overall

Patient Model

Patient Model

Age (categorical)

X

X

Congestive heart failure

X

X

Pulmonary circulation disease

X

Peripheral vascular disease

X

Covariates

Paralysis
Other neurological disorders

X
X

X

Chronic pulmonary disease

X
X

Diabetes with or without chronic complications

X

X

Hypothyroidism

X

X

Renal failure

X

Liver disease

X

X

Metastatic cancer

X

X
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Solid tumor without metastasis

X

X

Coagulopathy

X

X

Obesity

X

Weight loss

X

X

Fluid and electrolyte disorders

X

X

Chronic blood loss anemia

X

X

Deficiency anemias

X

X

Drug abuse

X

X

Psychoses

X

Depression

X

X

Hypertension

X

X

ICU, intensive care unit

We examined the relationship between intensive care unit admission rates and
risk-standardized mortality rates using a scatterplot and also compared mortality
rates across quartiles. Next, we compared the median length of stay across the
four quartiles. A Kruskal-Wallis test was used to assess statistical significance in
both the mortality rate and length of stay comparison. We then compared the rate
of critical care therapy use across quartiles. A Cochran-Armitage Trend test was
used to assess statistical differences in therapy use across quartiles. We
considered p-values <0.05 as statistically significant.
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Analyses were conducted with SAS version 9.3 (SAS Institute Inc., Cary,
NC). The GLIMMIX procedure was used to estimate the hierarchical logistic
models. We generated the figures with R version 2.9.1 (R Development Core
Team, Vienna, Austria).29 The statistical analysis on SAS as well as the
acquisition of the Premier database was performed by other members of the
research team. I was involved in the interpretation of the data and the design of
the study, including decisions on aims, study variables, primary and secondary
analyses, and statistical tests.

Results
Hospital Characteristics
We identified 114,136 hospitalizations for myocardial infarction in the 307
hospitals which admitted patients to an intensive care unit over the 2-year study
period. Of these hospitalizations, 54,527 (48%) involved admission to an
intensive care unit on the first hospital day. Among hospitals, the median bed
size was 302 (interquartile range: 186,432), median 2-year volume of
hospitalizations for myocardial infarction was 258 (interquartile range: 84,539),
and median 2-year volume of intensive care unit hospitalizations for myocardial
infarction was 112 (interquartile range: 34,265). Hospitals in our study tended to
be located in the South (39%), serve an urban population (83%), and identify as
non-teaching (71%; Table 2).
Following stratification into quartiles by intensive care unit admission rates
for patients with myocardial infarction, quartile 1 included hospitals with intensive
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care unit admission rates ≤34%. Quartile 2 included hospitals with rates of 35%48%. Quartile 3 included hospitals with rates of 49%-61%. Quartile 4 included
hospitals with rates ≥ 62%. Across quartiles, hospitals had similar
characteristics except that those with the lowest intensive care unit admission
rates (quartile 1) were smaller (42% had ≤200 beds compared with 28%, 22%,
and 20% in quartiles 2, 3, and 4, respectively) and had a lower 2-year case
volume of myocardial infarctions (38% had <85 hospitalizations for AMI
compared with 25%, 15% and 22% in quartiles 2, 3, and 4, respectively).
Table 2. Hospital Cohort Characteristics (N=307)
All
Quartile 1

Quartile 2

Quartile 3

Quartile 4

(n=77)

(n=76)

(n=78)

(n=76)

n(%)

n(%)

n(%)

n(%)

Hospitals
(n=307)
n(%)
Number of beds
1 – 200

85 (28)

32 (42)

21 (28)

17 (22)

15 (20)

201 – 400

130 (42)

27 (35)

36 (47)

31 (40)

36 (47)

401 – 600

64 (21)

14 (18)

14 (18)

19 (24)

17 (22)

>600

28 (9)

4 (5)

5 (7)

11 (14)

8 (11)

Volume of hospitalizations for acute MI*
25* – 84

77 (25)

29 (38)

19 (25)

12 (15)

17 (22)

85 – 258

77 (25)

17 (22)

21 (28)

18 (23)

21 (28)

259 – 539

77 (25)

15 (19)

19 (25)

21 (27)

22 (29)

>539

76 (25)

16 (21)

17 (22)

27 (35)

16 (21)

18 (24)

9 (12)

9 (12)

Volume of ICU hospitalizations for acute MI*
1 – 34

79 (25)

43 (56)

12
35 – 112

75 (25)

17 (22)

23 (30)

16 (21)

19 (25)

113 – 265

77 (25)

16 (21)

22 (29)

21 (27)

19 (24)

>265

76 (25)

1 (1)

13 (17)

32 (41)

30 (39)

Midwest

74 (24)

19 (25)

17 (22)

13 (17)

25 (33)

Northeast

49 (16)

17 (22)

12 (16)

13 (17)

7 (9)

South

119 (39)

27 (35)

32 (42)

30 (38)

30 (40)

West

65 (21)

14 (18)

15 (20)

22 (28)

14 (18)

Urban

254 (83)

60 (78)

62 (82)

68 (87)

64 (84)

Rural

53 (17)

17 (22)

14 (18)

10 (13)

12 (16)

Non-teaching

219 (71)

54 (70)

55 (72)

55 (71)

55 (72)

Teaching

88 (29)

23 (30)

21 (28)

23 (29)

21 (28)

Geographic region

Population served

Teaching status

MI, myocardial infarction; ICU, intensive care unit
*Categories were stratified by quartiles from the overall distribution of volume of
hospitalizations for acute MI and ICU hospitalizations for MI. Volume was measured across
the 2-year study period.

Among patients, the proportion of hospitalizations for ST-segment elevation
myocardial infarction ranged from 32% to 39% from quartile 1 to 4, while the
proportion of hospitalizations utilizing reperfusion therapy ranged from 44% to 51%
(Table 3). Other patient characteristics, including age, gender, and comorbidities
were largely similar across quartiles.
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Table 3. Patient Characteristics (n=114,136).
All Patients

Quartile 1

Quartile 2

Quartile 3

Quartile 4

(n=114,136)

(n=24,576)

(n=25,904)

(n=38,121)

(n=25,535)

(%)

(%)

(%)

(%)

(%)

18 – 54

21

18

21

22

24

55 – 64

23

20

22

23

24

65 – 74

21

21

21

22

20

75 – 84

20

22

21

20

19

≥85

15

18

16

14

13

Male

60

59

60

61

61

Female

40

41

40

39

39

ST-Segment Elevation

37

32

36

38

39

Non-ST-Segment

63

68

64

62

61

Yes

47

44

47

46

51

No

53

56

53

54

49

13

13

12

13

13

7

7

7

7

6

21

21

21

21

20

Age

Gender

Type of Myocardial Infarction

Elevation
Reperfusion

Comorbidities
Peripheral Vascular
Disease
Other Neurological
Disorders
Chronic Pulmonary
Disease
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Diabetes with and without
36

36

36

35

35

Hypothyroidism

11

11

11

11

10

Renal Failure

20

21

20

19

19

Coagulopthy

5

5

5

5

6

Obesity

13

13

13

14

13

22

23

21

23

23

Deficiency Anemias

19

19

18

19

19

Depression

8

8

8

8

7

Hypertension

70

71

70

70

71

Complications

Fluid and Electrolyte
Disorders

Intensive Care Unit Admission Rates
The intensive care unit admission rate for hospitalizations for myocardial
infarction among hospitals varied markedly with a range from 0% to 98% (median:
48%; interquartile range: 35-61%; Figure 1). The hospital with the lowest
admission rate did not have an absolute rate of 0% but rather, this figure was
obtained due to rounding. The median intensive care unit admission rates across
quartiles 1 through 4 were 20%, 41%, 55%, and 71%, respectively, and
demonstrate a sizeable increase in median admission rates from quartile 1 to
quartile 2.
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Figure 1. ICU Admission Rates across Hospitals for All Hospitalizations for
Myocardial Infarction (N=307). Each data point represents a hospital; ICU,
intensive care unit

Among the subgroups, intensive care unit admission rates across
hospitals within each patient group also varied widely despite differences in
median overall intensive care unit admission rates across patient groups. There
were 302 out of the 307 total hospitals which had patients with an ST-segment
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elevation myocardial infarction admitted to an intensive care unit, while there
were 306 out of the 307 total hospitals which had patients with a non STsegment elevation myocardial infarction admitted to an intensive care unit. The
median intensive care unit admission rate for patients with ST-segment elevation
myocardial infarction was 75% (range 0-100%, Figure 2), higher than the median
admission rate for all patients with myocardial infarction, while the median rate
for non-ST-segment elevation myocardial infarctions was 35% (range 0-96%,
Figure 3), lower than the median admission rate for all patients with myocardial
infarction.
There were 221 out of the 307 total hospitals which admitted patients who
underwent reperfusion therapy to an intensive care unit, while there were 306 out
of the 307 total hospitals which admitted patients who did not undergo
reperfusion therapy to an intensive care unit. The median intensive care unit
admission rate for patients who received reperfusion therapy was 67% (range 0100%, Figure 4), which was higher than the median admission rate for all
patients with myocardial infarction. The median rate for patients who did not
receive reperfusion therapy was 38% (range 0-97%, Figure 5), lower than the
median admission rate for all patients with myocardial infarction. Again, rates of 0%
were obtained due to rounding rather than a lack of patients admitted to an
intensive care unit.
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Figure 2. ICU Admission Rates across Hospitals for Patients with STEMI
(N=302). Hospitals with no patients admitted to an ICU with a STEMI are not
represented; ICU, intensive care unit; STEMI, ST-segment elevation myocardial
infarction.
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Figure 3. ICU Admission Rates across Hospitals for Patients with NSTEMI
(N=306). Hospitals with no patients admitted to an ICU with a NSTEMI are not
represented; ICU, intensive care unit; NSTEMI, non ST-segment elevation
myocardial infarction.
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Figure 4. ICU Admission Rates across Hospitals for Patients with
Myocardial Infarction Receiving Reperfusion Therapy (N=215). Hospitals with
no patients admitted to an ICU with a myocardial infarction who received
reperfusion therapy are not represented; ICU, intensive care unit.
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Figure 5. ICU Admission Rates across Hospitals for Patients with
Myocardial Infarction Not Receiving Reperfusion Therapy (N=306). Hospitals
with no patients admitted to an ICU with a myocardial infarction who did not
receive reperfusion therapy are not represented; ICU, intensive care unit.
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Mortality
There was no relationship between hospital intensive care unit admission
rates and in-hospital risk-standardized mortality rates for all patients with
myocardial infarction (Figure 6).

Figure 6. Overall In-Hospital Risk-Standardized Mortality Rates across
Hospital ICU Admission Rates for Myocardial Infarction (N=307). Each data
point represents a hospital; ICU, intensive care unit
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When compared across quartiles of intensive care unit admission, there
was no statistical difference in risk-standardized mortality rates. Quartile 1
hospitals had a collective mortality rate of 6.0% while hospitals in quartiles 2, 3,
and 4 had collective mortality rates of 6.0%, 6.1%, and 5.9%, respectively (p=0.7;
Table 4).

Table 4. Risk-Standardized In-Hospital Mortality across Hospitals for All Patients with
Myocardial Infarction (N=307).
Outcome

Risk-standardized in-

Category

N

Mortality rate (%)

Quartile 1

77

6.0

Quartile 2

76

6.0

P-value

0.73
hospital mortality

Quartile 3

78

6.1

Quartile 4

76

5.9

For the subgroup of intensive care unit patients with myocardial infarction, inhospital risk-standardized mortality rates differed significantly among quartiles.
The hospitals with the highest intensive care unit admission rates had the lowest
mortality (6.5% in quartile 4) while lower intensive care unit admission rates were
associated with higher mortality (7.1%, 7.9%, and 8.7% in quartiles 3, 2, and 1,
respectively; p<0.0001; Table 5).
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Table 5. Risk-Standardized In-Hospital Mortality across Hospitals for ICU Patients with
Myocardial Infarction (N=307).
Outcome

Risk-standardized in-

Category

N

Mortality rate (%)

Quartile 1

77

8.7

Quartile 2

76

7.9

P-value

<0.01
hospital mortality

Quartile 3

78

7.1

Quartile 4

76

6.5

ICU, intensive care unit

Use of Critical Care Therapy
All Patients with Myocardial Infarction
The proportion of all patients with myocardial infarction utilizing critical
care therapies increased across quartiles of increasing hospital intensive care
unit admission rates. From quartile 1 to 4, there was a significantly increasing
trend in the use of mechanical ventilation from 13% to 16% (p<0.01),
vasopressors or inotropes from 17% to 21% (p<0.01), intra-aortic balloon pumps
from 4% to 7% (p<0.01), and pulmonary artery catheters from 4% to %5 (p=0.04;
Table 6).
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Table 6. Critical Care Therapy Utilization across Hospitals for All Patients with Myocardial
Infarction (N=114,136)
Usage of therapy
(Proportion of hospitalizations utilizing therapy; %)
Quartile 1

Quartile 2

Quartile 3

Quartile 4

P-value

(n=24,576)

(n=25,904)

(n=38,121)

(n=25,535)

for Trend

13

15

15

16

<0.01

17

18

20

21

<0.01

Intra-aortic balloon pump

4

5

5

7

<0.01

Pulmonary artery catheter

4

6

5

5

0.04

Therapy
Mechanical ventilation
Vasopressors and/or
inotropes

Intensive Care Unit Patients with Myocardial Infarction
Among the subgroup of intensive care unit patients with myocardial
infarction, there was a significantly decreasing trend in the proportion of patients
receiving critical care therapies across quartiles of increasing intensive care unit
admission rates. From quartile 1 to 4, there was a decrease in the use of
mechanical ventilation from 28% to 18%, vasopressors or inotropes from 35% to
24%, intra-aortic balloon pumps from 12% to 9%, and pulmonary artery catheters
from 6% to 5% (p<0.01 for all therapies; Table 7).
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Table 7. Critical Care Therapy Utilization across Hospitals for ICU Patients with Myocardial
Infarction (N=54,527)
Usage of therapy
(Proportion of hospitalizations utilizing therapy; %)
Quartile 1

Quartile 2

Quartile 3

Quartile 4

P-value

(n=4,860)

(n=10,537)

(n=20,940)

(n=18,190)

for Trend

28

22

19

18

<0.01

35

26

25

24

<0.01

Intra-aortic balloon pump

12

9

8

9

<0.01

Pulmonary artery catheter

6

6

5

5

<0.01

Therapy
Mechanical ventilation
Vasopressors and/or
inotropes

ICU, intensive care unit

Length of Stay
All Patients with Myocardial Infarction
The median length of stay for all patients with myocardial infraction was
largely similar across quartiles. Quartiles 1, 2, and 4 all had a median length of
stay of 3 days, with an interquartile range of 2 to 6 days. Quartile 3 hospitals had
the longest length of stay at 4 days but similarly had an interquartile range of 2 to
6 days (p<0.0001; Table 8).
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Table 8. Length of Stay across Hospitals for All Patients with Myocardial Infarction
(N=114,980).
Length of Stay in days
Outcome

Category

P-value

N
Median (IQR)

Quartile 1

24,576

3 (2, 6)

Quartile 2

25,904

3 (2, 6)

Length of Stay

<0.0001*
Quartile 3

38,121

4 (2, 6)

Quartile 4

25,535

3 (2, 6)

*Global test

Intensive Care Unit Patients with Myocardial Infarction
Among the subgroup of intensive care unit patients with myocardial
infarction, there was a slight difference in length of stay across quartiles. Patients
admitted to the intensive care unit with myocardial infarctions at quartile 4
hospitals, those with the highest admission rates, had the shortest median length
of stay at 3 days (interquartile range: 2, 6). Quartile 3 hospitals had a median
length of 4 days (interquartile range: 2, 7), while quartile 2 hospitals had a
median length of stay of 4 days (interquartile range: 2, 6). Quartile 1 hospitals,
those with the lowest intensive care unit admission rates, had the longest median
length of stay of 4 days (interquartile range: 3, 7; p<0.0001; Table 9).
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Table 9. Length of Stay across Hospitals for ICU Patients with Myocardial Infarction
(N=54,527).
Length of Stay in days
Outcome

Category

P-value

N
Median (IQR)

Quartile 1

4,860

4 (3, 7)

Quartile 2

10,537

4 (2, 6)

Length of Stay

<0.0001*
Quartile 3

20,940

4 (2, 7)

Quartile 4

18,190

3 (2, 6)

*Global test; ICU, intensive care unit

Discussion
We found that intensive care unit admission rates for myocardial infarction
varied substantially across hospitals but were not associated with differences in
mortality after accounting for case mix. There was also little absolute difference
in overall length of stay. Hospitals admitting a greater percentage of patients to
the intensive care unit were more likely to perform invasive critical care
interventions overall. However, the use of these interventions and length of stay
was lower in these high-admitting hospitals among the subset of patients with
myocardial infarction admitted directly to the intensive care unit, suggesting that
at the margin, hospitals admitting a larger proportion of patients to the intensive

28

care unit were admitting a group of lower risk patients with weaker indications for
these therapies.
To our knowledge, this is the first study to examine hospital-level variation
in intensive care unit utilization for myocardial infarction and its association with
outcomes in such large sample of hospitals. Although intensive care may be
providing lifesaving interventions for the appropriate patients, it may not be
providing value for all patients admitted to an intensive care unit. The decision to
use an intensive care unit is important not only because intensive care units are
resource intensive settings,18 but also because these hospitalizations potentially
pose numerous inherent risks for patients including but not limited to various
sources of infection, venous thromboembolic disease, and delirium.30,31 Our
findings suggest that we may not be optimally utilizing these highly specialized
resources.
These findings highlight the decision to use an intensive care unit for
patients with a myocardial infarction as a potential target for improvement. As
early as 1987, Wagner noted a significant portion of the general intensive care
unit population in hospitals were low-risk patients admitted for monitoring, of
which only 4.3% received any critical care treatments, and called for a
reassessment of contemporary intensive care unit utilization to guide optimization
of use.32 More recent studies have shown little improvement in the landscape of
intensive care utilization today, as more than half of patients directly admitted to
intensive care units have a 30-day mortality of 2% or less.33 Furthermore,
hospitals demonstrate significant variation in their utilization of intensive care unit
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care for both all patients and patients with specific conditions such as acute
decompensated heart failure and diabetic ketoacidosis.33-36 We extend this work
to patients with myocardial infarction in a contemporary patient population.
Compared with previous work on heart failure patients and the overall patient
population, patients with myocardial infarction have a higher median hospital
intensive care unit admission rate and wider variation across hospitals
(interquartile range of 35-61% for patients with myocardial infarction versus 6-16%
for heart failure patients and 4.7-10% or 9-17% for all patients).33-35 Such
differences suggest that patients with myocardial infarction account for a
relatively higher cost and resource burden on the healthcare system overall and
high-admitting hospitals in particular, making this population a potentially high
yield target for optimization.
Our results suggest that variation across hospitals in intensive care unit
triage may be more due to hospital factors rather than patient characteristics. For
example, we found that patient demographics and comorbidities were
comparable across the four quartiles of hospitals. Wide variations in rates of
intensive care unit admission across hospitals were identified in all patient
subgroups. This includes patients with ST-segment and non- ST-segment
elevation myocardial infarctions, and patients who did and did not undergo
reperfusion therapy, suggesting that no particular group was responsible for this
overall hospital-level variation. Our findings are consistent with previous literature
for other conditions suggesting that patient characteristics explain only a modest
proportion of the variation in intensive care unit use.33 Despite efforts to
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standardize patient care through published algorithms and guidelines, the lack of
consistency in intensive care unit use likely still reflects a large discretionary
component that includes consideration of bed availability, patients’ wishes,
physician incentives, and differing beliefs about best practices, particularly across
different institutions.34,37,38
There are several possible explanations for our findings. First, hospitals
admitting a large proportion of patients with myocardial infarction to the intensive
care unit may have lower thresholds for intensive care unit admission, thereby
using intensive care for lower-risk patients who are less likely to have adverse
outcomes or need critical care therapies. Consistent with this hypothesis, we
found a trend that intensive care unit patients with myocardial infarction were less
likely to receive critical care interventions and had lower mortality at higheradmitting hospitals. Also supporting this hypothesis, these intensive care unit
patients at the highest-admitting hospitals also had the shortest median length of
stay while the lowest-admitting hospitals had the longest length of stay. When
considered in combination with the overall lack of difference in mortality, this
further suggests that hospital patient-risk thresholds for admission to an intensive
care unit may be very different between high- and low-admitting hospitals. An
alternative explanation for this trend may be that high-admitting hospitals are
improving patient outcomes with intensive care unit admission. However, this
seems unlikely given that across quartiles, patient characteristics were similar
and overall mortality rates for myocardial infarction did not differ despite such
widely varying rates of intensive care unit and critical care therapy use.
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Our results have important implications for health system leaders and
policymakers seeking to improve the efficiency of inpatient care. This pattern of
care for myocardial infarction in high-admitting hospitals—higher overall use of
intensive care units and critical care therapies across all patients combined with
the lower use of critical care therapies per intensive care unit patient—suggests
an opportunity where improving triage could enhance resource utilization without
undermining outcomes.
Several strategies may provide practical approaches to improve use of the
intensive care unit for patients with a myocardial infarction. At the provider level,
a renewed emphasis may need to be placed on the use of appropriate risk
stratification for patients with myocardial infarction at presentation. Well-validated
risk prediction models exist to accurately predict in-hospital adverse cardiac
outcomes, such as the well-known Global Registry of Acute Coronary Events
(GRACE) and the Thrombolysis in Myocardial Infarction (TIMI) scores.39,40 Other
studies have specifically identified clinical features and risk factors that predict
complications and critical care needs.41 Low-risk patients identified with these
tools have excellent in-hospital and long-term outcomes and therefore may not
routinely require intensive care unit admission. Furthermore, for many patients
admitted to intensive care units for monitoring and prevention of complications,
intermediate care units such as step-down units or general telemetry units may
provide an equally safe yet more cost-effective alternative. Finally, risk prediction
models can also effectively guide admission to these units in an effort to optimize
utilization and cost through a more gradated system of care.42
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In addition to these strategies, future investigation should focus on better
understanding the drivers of these hospital-level variations or phenotypes, the
population of patients with myocardial infarction who most benefit from intensive
care unit admission, and the point at which marginal benefit from intensive care
unit admission ceases. A few studies have demonstrated that certain subsets of
patients with acute myocardial infarction, such as low-risk patients who
underwent successful reperfusion through percutaneous coronary intervention,
have similar outcomes whether they are admitted to a general medicine ward or
to an intensive care unit.10,20,22 However, more of these studies are needed in
order to determine all of the patient subgroups, patient characteristics, and
clinical markers which may influence whether or not intensive care admission can
influence outcomes. Additional research utilizing clinical databases or registry
may be the next steps in better understanding this distinction. In addition,
detailed investigations utilizing both quantitative and qualitative methods to
analyze various samples of hospitals from each of these quartiles of intensive
care unit utilization may elucidate which hospital factors have the largest effect
on dictating patient triage and allow us to better understand the discretionary
components of use.
Such investigations and future studies of these resource-intensive settings
are particularly relevant as healthcare spending in the United States continues to
escalate, gaining attention and notoriety in both the political arena and the public
eye. Even as the economy has slowed in recent years, healthcare expenditures
continued to grow each year, reaching $2.7 trillion in 2011.43 Intensive care
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accounts for a substantial proportion of these expenditures, with costs exceeding
$80 billion as of 2005 and growing.19 Recently, a significant amount of literature
has focused on the need for effective and efficient use of critical care in order to
maximize its value. Articles in prominent, high-impact journals have promoted the
use of several multidisciplinary strategies to improve critical care utilization,
including health information technology capitalizing on integrated health systems
and electronic health records,44 as well as the economic concept of demand
elasticity and the need to understand or control the influence of intensive care
unit bed availability on utilization.45 These multidisciplinary, high-level
approaches should go hand in hand with our suggested need to understand the
hospital-level influences on discretionary use and varying institutional cultures,
and complement potentially more granular approaches to optimizing critical care
for high-value diseases such as myocardial infarction.
Several factors should be considered in interpreting our results. Our study
focused on hospital patterns so we cannot make an inference about the utility of
admission to an intensive care unit for any particular patient. We performed
hospital risk adjustment using age, sex, and comorbidities derived from
administrative data. Although clinical data are typically superior to claims data for
patient-level risk adjustment, claims-based hospital-level risk adjustment has
been shown to produce similar results at the hospital level, particularly for
myocardial infarctions.26,27 Our study also depended on the reliability of the
administrative and billing data to distinguish between intensive care unit and nonintensive care unit beds. However, due to the large discrepancy in billing costs
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between these bed types, we feel confident that hospitals would ensure these
billing codes are accurate as they potentially represent a significant difference in
compensation. In addition, we were unable to apply a clinical risk score to assess
the extent to which intensive care unit use was calibrated to patients’ underlying
clinical risk. We were also unable to track patients after hospital discharge so
longer-term outcomes could not be evaluated. Finally, our hospital cohort may
not be representative of general intensive care unit triage patterns nationwide;
however, the Premier network covers much of the United States.
In conclusion, we revealed marked variation in intensive care unit
admission across hospitals for patients admitted with myocardial infarction. We
failed to find any relationship between more intensive use of intensive care units
and better outcomes, even though aggressive intensive care unit use was
associated with greater use of critical care resources. The pattern among those
patients admitted to the intensive care unit suggests that hospitals with higher
utilization may have a lower threshold for admitting patients. These findings
identify an opportunity to improve intensive care unit use through optimizing
triage decisions and determining which patients truly derive benefit from the
intensive care setting.
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